Trial intelligence / Profile preview

ASU-VAC: COVID-19 Vaccine Effectiveness

NCT04885764Phase 3Unknown

Sponsor
Ain Shams University
Start
Feb 2021
Primary completion
Oct 2021
Modality
Viral Vector Vaccines
Countries
1
01

Overview

A Phase 3 trial of ChAdOx1 nCoV-19, BBIBP-CorV in coronavirus disease 2019 (COVID-19), sponsored by Ain Shams University. Status: unknown.

02

Drugs

ChAdOx1 nCoV-19BBIBP-CorV
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT04885764.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04885764.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call